Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2024-07-18 Capital/Financing Update
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Gencurix, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It outlines the terms of a third-party capital increase, including share issuance, pricing, and payment dates. This falls under the category of capital structure changes and financing activities, which is classified as 'CAP' (Capital/Financing Update).
2024-07-18 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Gencurix, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). This is a formal regulatory filing in Korea (DART system) announcing a capital structure change through a third-party share issuance. Since it details the issuance of new shares, pricing, and purpose, it falls under the 'Share Issue/Capital Change' category.
2024-06-24 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from Gencurix regarding the acquisition of convertible bonds before maturity (early redemption). It details the bond series, acquisition amount, reason for acquisition (put option exercised by bondholders), and the method of cancellation. This falls under capital structure changes and financing updates, specifically related to debt instruments.
2024-06-10 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 젠큐릭스' (Gencurix Inc.) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial information, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of a specific asset transfer (sale of shares in another company, NGeneBio) by Gencurix. While the title mentions 'merger', the content specifically describes a divestment/asset disposal transaction. Since this document reports the finalization of a corporate transaction (M&A/divestment activity) rather than a general regulatory announcement or a report publication notice, it falls under the M&A Activity category.
2024-04-19 Korean
주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the decision to dispose of shares in another company (타법인 주식 및 출자증권 양도결정). This is a specific regulatory disclosure required for material corporate events, such as the sale of equity investments, which falls under the category of general regulatory filings for material corporate actions.
2024-04-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.